81 related articles for article (PubMed ID: 2602432)
1. Serum antibodies to cholinergic neurons in Alzheimer's disease.
Michaelson DM; Chapman J; Bachar O; Korczyn AD; Wertman E
Prog Clin Biol Res; 1989; 317():689-94. PubMed ID: 2602432
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons.
Chapman J; Bachar O; Korczyn AD; Wertman E; Michaelson DM
J Neurosci; 1989 Aug; 9(8):2710-7. PubMed ID: 2475591
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to the heavy neurofilament subunit (NF-H) of Torpedo cholinergic neurons.
Faigon M; Hadas E; Alroy G; Chapman J; Auerbach JM; Michaelson DM
J Neurosci Res; 1991 Aug; 29(4):490-8. PubMed ID: 1791640
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to cholinergic neurons in Alzheimer's disease.
Chapman J; Bachar O; Korczyn AD; Wertman E; Michaelson DM
J Neurochem; 1988 Aug; 51(2):479-85. PubMed ID: 3292704
[TBL] [Abstract][Full Text] [Related]
5. Antibodies from Down's syndrome patients bind to the same cholinergic neurofilament protein recognized by Alzheimer's disease antibodies.
Hassin-Baer S; Wertman E; Raphael M; Stark V; Chapman J; Michaelson DM
Neurology; 1992 Mar; 42(3 Pt 1):551-5. PubMed ID: 1532232
[TBL] [Abstract][Full Text] [Related]
6. Immunization of rats with cholinergic neurons induces behavioral deficits.
Chapman J; Feldon J; Alroy G; Michaelson DM
J Neural Transplant; 1989; 1(2):63-76. PubMed ID: 2519521
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease.
Soussan L; Tchernakov K; Bachar-Lavi O; Yuvan T; Wertman E; Michaelson DM
Mol Neurobiol; 1994; 9(1-3):83-91. PubMed ID: 7888108
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides.
Mruthinti S; Buccafusco JJ; Hill WD; Waller JL; Jackson TW; Zamrini EY; Schade RF
Neurobiol Aging; 2004 Sep; 25(8):1023-32. PubMed ID: 15212827
[TBL] [Abstract][Full Text] [Related]
10. Decreased density of forebrain cholinergic neurons in experimental autoimmune dementia.
Dubovik V; Faigon M; Feldon J; Michaelson DM
Neuroscience; 1993 Sep; 56(1):75-82. PubMed ID: 8232919
[TBL] [Abstract][Full Text] [Related]
11. Decreased density of forebrain cholinergic neurons and disintegration of the spatial organization of behavior in experimental autoimmune dementia (EAD).
Michaelson DM; Dubovik V; Faigon M; Eilam D; Feldon J
Ann N Y Acad Sci; 1993 Sep; 695():244-8. PubMed ID: 8239291
[TBL] [Abstract][Full Text] [Related]
12. Animal model and in vitro studies of anti neurofilament antibodies mediated neurodegeneration in Alzheimer's disease.
Oron L; Dubovik V; Novitsky L; Eilam D; Michaelson DM
J Neural Transm Suppl; 1997; 49():77-84. PubMed ID: 9266416
[TBL] [Abstract][Full Text] [Related]
13. The antigenic structure of the acetylcholine receptor from Torpedo californica.
Gullick WJ; Lindstrom JM
J Cell Biochem; 1982; 19(3):223-30. PubMed ID: 6185511
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders.
Whitehouse PJ; Kellar KJ
J Neural Transm Suppl; 1987; 24():175-82. PubMed ID: 2960781
[TBL] [Abstract][Full Text] [Related]
15. Anti-neuronal antibodies similar to those found in Alzheimer's disease induce memory dysfunction in rats.
Chapman J; Alroy G; Weiss Z; Faigon M; Feldon J; Michaelson DM
Neuroscience; 1991; 40(2):297-305. PubMed ID: 2027463
[TBL] [Abstract][Full Text] [Related]
16. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
Mufson EJ; Jaffar S; Levey AI
J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
[TBL] [Abstract][Full Text] [Related]
17. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
18. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an experimental autoimmune dementia model in the rat.
Michaelson DM; Alroy G; Goldstein D; Chapman J; Feldon J
Ann N Y Acad Sci; 1991; 640():290-4. PubMed ID: 1776754
[TBL] [Abstract][Full Text] [Related]
20. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
Rasool CG; Svendsen CN; Selkoe DJ
Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
